MetaCap

Aspen Neuroscience Inc. (ASPE)

NASDAQ: ASPEHealth CareBiotechnology: Pharmaceutical PreparationsUSD

12.42+0.03 (+0.24%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

ASPE stock chart

Technical analysis

Key statistics

All statistics
Market cap
$361.16M
EPS (TTM)
-$4.89
52-week range
11.20 – 14.90
Day range
12.17 – 13.19
Volume / Avg
130.04K / 352.42K
Beta
—

52-week range

$11.20$14.90

ASPE stock today

On Nov 20, ASPE ended the session at $12.42, adding $0.03 (0.24%), versus the S&P 500's 3.70% decline. Trading was light, with 130.04K shares changing hands, about 37% of the average daily volume. Shares are 16.6% below their 52-week high of $14.90, set on Oct 30, 2026 and 10.9% above the 52-week low of $11.20, in the middle of the past year's range.

Aspen Neuroscience has posted a net loss over the last twelve months (EPS of -$4.89), so its P/E ratio is not meaningful.

Summary generated from market data by MetaCap's automated system. Methodology

About Aspen Neuroscience

Company profile

Aspen Neuroscience, Inc. develops autologous induced pluripotent stem cell (iPSC)-derived cell replacement therapies for neurodegenerative diseases. The company's develops ANPD001, an investigational single-dose, autologous dopaminergic neuronal precursor cell (DANPC) therapy for Parkinson's disease.

Industry
Biotechnology: Pharmaceutical Preparations
CEO
Dr. Damien McDevitt Ph.D.
Headquarters
San Diego, CA
Employees
120
IPO year
2026

Aspen Neuroscience peers

Health Care sector
ASPE peer companies
CompanyPrice% ChgMarket capCompare
PEPGPepGen Inc.3.78-3.82%$356.31Mvs ASPE
PBYIPuma Biotechnology Inc7.05-0.98%$364.47Mvs ASPE
PHATPhathom Pharmaceuticals Inc.4.66-8.27%$378.82Mvs ASPE
CTNMContineum Therapeutics Inc. Class A8.68-3.98%$340.83Mvs ASPE
IRDOpus Genetics Inc.3.99-2.21%$385.65Mvs ASPE
MPLTMapLight Therapeutics Inc.5.94-7.48%$330.12Mvs ASPE
AVTXAvalo Therapeutics Inc.6.76+0.15%$390.88Mvs ASPE
INOInovio Pharmaceuticals Inc.1.76+2.92%$329.66Mvs ASPE

Indexes, lists and sector

Aspen Neuroscience stock FAQ

What is Aspen Neuroscience's stock price today?

ASPE last traded at $12.42 as of Nov 20, 4:00 PM EST, up 0.24% on the day. Prices are delayed at least 15 minutes.

Who is Aspen Neuroscience's CEO?

Dr. Damien McDevitt Ph.D. is the chief executive officer of Aspen Neuroscience Inc., which has about 120 employees.

What is the ASPE 52-week high?

The 52-week high for ASPE is $14.90 and the 52-week low is $11.20. The stock is currently 16.6% below its high.

Compare ASPE